University of California, Irvine
Neurological Surgery residency · Orange, CA · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of California, Irvine's research in neurological surgery, which the program shares with other departments and affiliated hospitals.
About University of California, Irvineinstitution-wide neurological surgery research
Neurological Surgery publications from University of California, Irvine and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
254
works per year
26th of 55 neurological surgery residency programs
+9.7%
2-year growth
39th of 55 neurological surgery residency programs
20.4%
in top 10% of field (works before 2025)
30th of 55 neurological surgery residency programs
49.4%
cited above world average
19th of 55 neurological surgery residency programs
Works per year · * 2026 so far
Surgery · 1,096Neurology · 163
Neurological Surgery research topics at University of California, Irvine
Papers in the window; each links to the list on OpenAlex.
- Neuroinflammation and Neurodegeneration Mechanisms 93
- Head and Neck Surgical Oncology 80
- Intraperitoneal and Appendiceal Malignancies 56
- Bladder and Urothelial Cancer Treatments 51
- Lipoproteins and Cardiovascular Health 40
- Nasal Surgery and Airway Studies 40
- Surgical site infection prevention 38
- Genital Health and Disease 37
Most cited at University of California, Irvine since 2024
All neurological surgery papers there on OpenAlex
- Neuroinflammation in Alzheimer diseaseMichael T. Heneka et al. · Nature reviews. Immunology · 2024 · PubMed · cited 642
- Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 studyDo‐Youn Oh et al. · The Lancet. Gastroenterology & hepatology · 2024 · PubMed · cited 325
- Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healingSergei Butenko et al. · Nature Communications · 2024 · PubMed · cited 230
- 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomitingJørn Herrstedt et al. · ESMO Open · 2024 · PubMed · cited 206
- Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trialAndrea Necchi et al. · The Lancet Oncology · 2024 · PubMed · cited 105
- TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomesYohann Loriot et al. · Annals of Oncology · 2024 · PubMed · cited 98
- Sex-dependent APOE4 neutrophil–microglia interactions drive cognitive impairment in Alzheimer’s diseaseNeta Rosenzweig et al. · Nature Medicine · 2024 · PubMed · cited 90
- Immune checkpoint TIM-3 regulates microglia and Alzheimer’s diseaseKimitoshi Kimura et al. · Nature · 2025 · PubMed · cited 86
- Therapeutic potential of human microglia transplantation in a chimeric model of CSF1R-related leukoencephalopathyJean Paul Chadarevian et al. · Neuron · 2024 · PubMed · cited 84
- Microglia protect against age-associated brain pathologiesDavid A. D. Munro et al. · Neuron · 2024 · PubMed · cited 82